Evaluation of the implementation of a protocol for the restrictive use of oxytocin during spontaneous labor

J Gynecol Obstet Hum Reprod. 2020 Feb;49(2):101664. doi: 10.1016/j.jogoh.2019.101664. Epub 2019 Dec 5.

Abstract

Introduction: Use of oxytocin is associated with uterine hyperstimulation and postpartum hemorrhage with a dose-dependent effect. We aimed to evaluate the effect of the implementation of a protocol for the restrictive use of oxytocin during spontaneous labor on obstetric and neonatal outcomes.

Material and methods: We performed an observational before-and-after study among 2174 women in spontaneous labor with a term singleton cephalic fetus. Obstetric and neonatal outcomes were compared according to the period, before (period A) and after (period B) the implementation of a protocol for the restrictive use of oxytocin.

Results: 1235 women were included in period A and 939 in period B. Compared to period A, the use of oxytocin during period B was significantly lower (45.5 vs. 35.1%, p<0.001) in both nulliparous (61.2 vs 54.6%, p=0.04) and multiparous women (34.0 vs. 21.1%, p<0.001). Labor was significantly longer in period B, both in nulliparous (6.7 vs. 7.9 h, p<0.01) and multiparous women (4.1 vs. 4.5 h, p<0.01). A lower frequency of uterine hyperstimulation (6.6 vs. 2.7%, p=0.01) was observed in period B. The odds of instrumental and cesarean delivery were not different between the periods (respectively adjusted odds ratio (AOR), 95% confidence interval (CI), 1.1(0.8-1.4); 1.2(0.8-1.8)) including for nulliparous women (respectively, 1.3(0.9-1.7); 1.3(0.8-1.9)).

Discussion: Reducing the use of oxytocin during spontaneous labor through the implementation of a protocol may reduce the iatrogenic effects without increasing the risk of caesarean section but this implies longer duration of labor.

Keywords: Augmentation of labor; Cesarean; Monitoring protocol; Oxytocin; Prolonged labor; Spontaneous labor.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Female
  • Guideline Adherence / statistics & numerical data*
  • Humans
  • Infant, Newborn
  • Labor, Obstetric / drug effects*
  • Oxytocics / administration & dosage*
  • Oxytocics / pharmacology
  • Oxytocin / administration & dosage*
  • Oxytocin / pharmacology
  • Pregnancy
  • Pregnancy Outcome*
  • Young Adult

Substances

  • Oxytocics
  • Oxytocin